This is consistent with our previous findings indicating that FMOD activates integrin signaling via type I collagen to engage the FAK-Src-Rho-ROCK pathway and promote the migration of glioma cells (Mondal et al., 2017). The gene discussed is SRC; the disease is central nervous system cancer.